![Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami]()
by admin | Jan 23, 2018 | News & Opinions
MIAMI, Jan. 22, 2018 /PRNewswire/ — Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company’s hometown of Miami for the 2018 World Stem Cell Summit,...
![Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami]()
by admin | Jan 21, 2018 | News & Opinions, Science
Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...
![Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami]()
by admin | Jan 21, 2018 | News & Opinions, Science
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
![Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami]()
by admin | Jan 21, 2018 | News & Opinions, Science
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
![Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami]()
by admin | Jan 21, 2018 | News & Opinions
PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...
